EUVIMEDOpdag EUVIMED
FallberichtÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

An Unusual Case of Cutaneous Langerhans Cell Sarcoma Lacking S100 Expression: A Case Report and Review of the Literature

Randa Obid, Austin R Green, Sion W Jasmine, Rachel P Kowal, Brooj Abro, Laura M Warmke, Magdalena B Czader, Ahmed K Alomari iD, Carina A Dehner

Journal of Cutaneous Pathology · 2025

DOI: 10.1111/cup.14833 ↗

At a glance

Fallbericht in Journal of Cutaneous Pathology, 2025. Written by Randa Obid and 8 co-authors. Institution: University of Louisville, Louisville, Kentucky, USA. Major MEDLINE topics: Langerhans Cell Sarcoma, Skin Neoplasms, S100 Proteins. Cited 1 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Langerhans cell sarcoma (LCS) is a rare neoplastic proliferation of Langerhans cell with aggressive clinical behavior and involves multiple organ systems, including the skin. LCS is characterized by marked cytologic atypia, frequent mitoses including atypical ones, and expression of CD1a, S100, and langerin (CD207). CD1a and Langerin‐positive but S100− negative LCS is extremely rare in clinical practice. We present a case of a 71‐year‐old female with a history of melanoma and atypical fibroxanthoma who presented with an erythematous plaque on her left knee. Histopathologic examination revealed a dermal infiltrate comprised of large pleomorphic cells with irregular nuclear contours, prominent longitudinal grooves, and vesicular chromatin, and a high mitotic rate. Notably, there were epidermotropism and a distinctive immunohistochemical profile: S100−, CD1a+, Langerin+, and focal CD68+. Next‐generation sequencing identified copy number loss of CDKN2A , CDKN2B , and FOXA1 , mutations in TP53 , POT1 , SH2B3 , and SMARCA4 , and a high tumor mutational burden. Herein, we discuss the clinical and pathologic features of 38 cases of LCS with cutaneous involvement reported in the literature, including recent advances in understanding molecular characteristics of this disease. This exceptional case may contribute to our understanding of the etiology of this rare neoplasm.

Subjects

MeSH terms (MEDLINE)

Langerhans Cell SarcomaSkin NeoplasmsS100 ProteinsHumansFemaleAgedBiomarkers, TumorImmunohistochemistryMelanoma

Author keywords

BRAFCDKN2ALangerhans cellLangerhans cell sarcomaMAPK pathway

Substances

S100 ProteinsBiomarkers, Tumor

Authors and institutions

  • University of Louisville, Louisville, Kentucky, USA.
  • Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, Indiana, USA.
  • Georgia Dermatopathology Partners, Brookhaven, Georgia, USA.
  • Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.

ORCID profiles: Ahmed K Alomari

Cite

APA

Obid, R., Green, A. R., Jasmine, S. W., Kowal, R. P., Abro, B., Warmke, L. M., Czader, M. B., Alomari, A. K., & Dehner, C. A. (2025). An Unusual Case of Cutaneous Langerhans Cell Sarcoma Lacking S100 Expression: A Case Report and Review of the Literature. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14833

Vancouver

Obid R, Green AR, Jasmine SW, Kowal RP, Abro B, Warmke LM, et al. An Unusual Case of Cutaneous Langerhans Cell Sarcoma Lacking S100 Expression: A Case Report and Review of the Literature. Journal of Cutaneous Pathology. 2025. doi:10.1111/cup.14833

BibTeX
@article{Obid2025,
  author = {Obid, Randa and Green, Austin R and Jasmine, Sion W and Kowal, Rachel P and Abro, Brooj and Warmke, Laura M and Czader, Magdalena B and Alomari, Ahmed K and Dehner, Carina A},
  title = {An Unusual Case of Cutaneous Langerhans Cell Sarcoma Lacking S100 Expression: A Case Report and Review of the Literature},
  journal = {Journal of Cutaneous Pathology},
  year = {2025},
  doi = {10.1111/cup.14833}
}
Start for free →